Results 251 to 260 of about 2,009,467 (292)

Third party podiatry

Journal of the American Podiatric Medical Association, 1973
openaire   +2 more sources

The Third Party

Southern Medical Journal, 1960
openaire   +2 more sources

Third Party Dentistry

Dental Clinics of North America, 1981
openaire   +2 more sources

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Lancet, The, 2021
Noam Barda, Noa Dagan, Cyrille J Cohen
exaly  

Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management

Nature Reviews Clinical Oncology, 2022
Lecia V Sequist, Jessica J Lin
exaly  

Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)

Lancet, The, 2021
Amy Flaxman, Daniel Jenkin, Sandra Belij-Rammerstorfer   +2 more
exaly  

Third party concerns

Cancer, 1989
openaire   +2 more sources

Third Parties

2022
openaire   +1 more source

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Lancet, The, 2021
Alasdair P S Munro, Victoria R Cornelius, Katrina Cathie   +2 more
exaly  

Third Party Funder

The Journal of the American Dental Association, 1973
openaire   +2 more sources